NCT02044250View on ClinicalTrials.gov

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)

PHASE4CompletedINTERVENTIONAL
Enrollment

5,530

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2020

Study Completion Date

March 31, 2021

Conditions
Coronary Heart Disease
Interventions
DRUG

Clopidogrel

Clopidogrel 75mg 1tab P.O. daily

DRUG

Aspirin

Aspirin 100\~200mg 1\~2tab P.O. daily

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Chong Kun Dang Pharmaceutical

INDUSTRY

collaborator

Samjin Pharmaceutical Co., Ltd.

INDUSTRY

collaborator

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

collaborator

Hanmi Pharmaceutical co., ltd.

OTHER

lead

Seoul National University Hospital

OTHER